Literature DB >> 12435583

Homocysteine promotes the LDL oxidase activity of ceruloplasmin.

M Exner1, M Hermann, R Hofbauer, B Hartmann, S Kapiotis, B Gmeiner.   

Abstract

Ceruloplasmin (CP) oxidises low density lipoprotein (LDL). The oxidising potential depends on the formation of Cu(+)-CP which is redox-cycled during oxidation. Homocysteine (HCY) reduces free Cu(2+), potentiating its cell-damaging property. We show that HCY enhanced LDL oxidation by CP, but did not activate the LDL oxidising potential of Cu(2+)-diamine oxidase. Selective removal of the redox-active Cu(2+) abolished the LDL oxidase activity of CP. However, HCY partially restored the LDL oxidase activity of redox-copper depleted CP, indicating that the remaining six copper atoms in CP may also be involved in the process. Spectroscopic and oxidation inhibition studies using the Cu(+)-reagent bathocuproine revealed that HCY induced Cu(+)-CP formation, thus promoting its LDL oxidase activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435583     DOI: 10.1016/s0014-5793(02)03571-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Identifying a role for the interaction of homocysteine and copper in promoting cardiovascular-related damage.

Authors:  Megha Gupta; Jiries Meehan-Atrash; Robert M Strongin
Journal:  Amino Acids       Date:  2021-04-22       Impact factor: 3.520

2.  Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury.

Authors:  Daoyin Dong; Biao Wang; Wen Yin; Xueqing Ding; Jingjing Yu; Y James Kang
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

3.  Molecular pathophysiology of diabetes mellitus during pregnancy with antenatal complications.

Authors:  Arthur T Kopylov; Olga Papysheva; Iveta Gribova; Galina Kotaysch; Lubov Kharitonova; Tatiana Mayatskaya; Ekaterina Sokerina; Anna L Kaysheva; Sergey G Morozov
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.